Geopolitics Alpha

Market closed · last trade · ETF proxies, Alpaca IEX

Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)

Published . Updated .

Key takeaways

  • Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
  • Exposed: SLDB, LLY, BLSH, XLV, XBI
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Directly affected

  • SLDB Solid Biosciences-10.9% 30d

    Named in this report.

  • LLY Eli Lilly+25.0% 30d

    Named in this report.

  • BLSH Bullish-14.1% 10d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

  • ABBV AbbVie+10.8% 30d

    AbbVie (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
SLDB+3.67%+1.28%baseafter closeafter closeafter closeafter close
LLY+6.37%+2.56%baseafter closeafter closeafter closeafter close
BLSH+3.54%+6.82%baseafter closeafter closeafter closeafter close
XLV+5.96%+2.17%baseafter closeafter closeafter closeafter close
XBI+4.00%+3.40%baseafter closeafter closeafter closeafter close
JNJ+4.35%+0.70%baseafter closeafter closeafter closeafter close
PFE+5.31%+2.32%baseafter closeafter closeafter closeafter close
MRK+8.11%+3.06%baseafter closeafter closeafter closeafter close
ABBV+2.84%-0.14%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY) The Globe and Mail

Source: The Globe and Mail

Select Sector Spdr Tr (XLV) since this story, compared with the market

CompanyWhenMoveStatus
ABBVthree days earlier-0.14%final price
ABBVfive days earlier+2.84%final price
BLSHthree days earlier+6.82%final price
BLSHfive days earlier+3.54%final price
Johnson & Johnson (JNJ)three days earlier+0.70%final price
Johnson & Johnson (JNJ)five days earlier+4.35%final price
Eli Lilly (LLY)three days earlier+2.56%final price
Eli Lilly (LLY)five days earlier+6.37%final price
Merck (MRK)three days earlier+3.06%final price
Merck (MRK)five days earlier+8.11%final price
Pfizer (PFE)three days earlier+2.32%final price
Pfizer (PFE)five days earlier+5.31%final price
SLDBthree days earlier+1.28%final price
SLDBfive days earlier+3.67%final price
Spdr Series Trust (XBI)three days earlier+3.40%final price
Spdr Series Trust (XBI)five days earlier+4.00%final price
Select Sector Spdr Tr (XLV)three days earlier+2.17%final price
Select Sector Spdr Tr (XLV)five days earlier+5.96%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around Select Sector Spdr Tr (XLV)

Companies mentioned with this story

  • XLV Select Sector Spdr Tr

    For “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story

  • XBI Spdr Series Trust

    In “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story

  • LLY Eli Lilly

    Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 21 Nov 2026 story “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY).” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story

  • JNJ Johnson & Johnson

    For “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story

  • PFE Pfizer

    For “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY),” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story

  • MRK Merck

    In “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story

Select Sector Spdr Tr (XLV)

On 21 Nov 2026, “Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)” is the story that connects Select Sector Spdr Tr (XLV) to this story.

What ties Select Sector Spdr Tr (XLV) to the headline is this: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story

A second company, Spdr Series Trust (XBI), is listed for a different reason: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story

Dates and price levels for Select Sector Spdr Tr (XLV)

LLY traded between 1239.21 and 1458.90 across 20 sessions. The latest close on file is 1430.09.

How strong the case is around Select Sector Spdr Tr (XLV)

46 out of 100

“Analysts Are Bullish on Top Healthcare Stocks: Solid Biosciences (SLDB), Eli Lilly & Co (LLY)” scores 46 out of 100. The score uses 1 source, and 6 linked companies.